GLP3-RT (20mg)

GLP3-RT is a triple agonist peptide engineered to target the GLP-1, GIP, and glucagon receptors. By integrating these three metabolic pathways, it achieves synergistic effects on fat reduction and glycemic control that exceed those of single or dual agonists. GLP3-RT simultaneously suppresses appetite, enhances insulin sensitivity, and increases resting energy expenditure through glucagon receptor activation—a unique mechanism that promotes fat oxidation and significant liver fat reduction.